Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin

C. N. Krasner, C. Castro, R. T. Penson, M. Roche, U. A. Matulonis, M. A. Morgan, C. Drescher, D. K. Armstrong, J. K. Wolfe, H. Lee, J. G. Supko, M. Seiden, M. J. Birrer, D. S. Dizon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin'. Together they form a unique fingerprint.

Medicine & Life Sciences